Kezar Life Sciences to Present at H.C. Wainwright Virtual BioConnect Conference
Kezar Life Sciences Added to the Nasdaq Biotechnology Index
Kezar Life Sciences to Present During Upcoming Virtual Investor Conferences
Kezar Life Sciences Reports Third-Quarter 2020 Financial Results and Provides Business Updates
Kezar Highlights Broad Therapeutic Potential of KZR-616 During ACR Convergence 2020
